Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Investment analysts at Leerink Partnrs boosted their Q1 2024 EPS estimates for Exact Sciences in a research note issued to investors on Wednesday, February 21st. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will earn ($0.36) per share for the quarter, up from […]
Exact Sciences Announces Fourth Quarter 2023 Results lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Akumin (NASDAQ:AKUMQ – Get Free Report) and Exact Sciences (NASDAQ:EXAS – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk. Earnings and Valuation This table compares Akumin and Exact […]